JADE TEAL: Open Payments
NPI 1831757764 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 46 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $242 |
| Axsome Therapeutics, Inc. | 12 | $184 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Lilly USA, LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Radius Health, Inc. | 3 | $44 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: Auvelity, Ozempic, Wegovy, BIJUVA, GEMTESA, MOUNJARO, CAPLYTA, FARXIGA.
Industry payments across TX — which companies pay providers there.
